BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
See today's BioWorld
Home
» Glycotope bags $90M in Octapharma coagulation protein glycosylation deal
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Glycotope bags $90M in Octapharma coagulation protein glycosylation deal
Oct. 9, 2015
By
Cormac Sheridan
No Comments
DUBLIN – Glycosylation specialist Glycotope GmbH is getting €80 million (US$90 million) up front as part of a licensing and equity investment deal with Octapharma AG covering a preclinical portfolio of blood coagulation factors.
BioWorld